Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd

OsStic^® and related technologies represent differentiated solutions that address an estimated 100,000+ procedures in the U.S. annually⁽¹⁾; arrangement leverages Sanara’s existing call points and commercial infrastructure, and complements Sanara’s existing surgical portfolio

Read more at globenewswire.com